MARKETS
Markets

10x Genomics Begins Commercial Shipments Of Its Transcriptome Analysis Tool Atera

Sep 29, 2026 · 09:11 AM ET· updated 1h ago

Atera is moving into the hands of researchers around the world, from those scaling existing spatial programs to researchers exploring spatial biology for the first time, across discovery, translational and biopharma

Share
Why It Matters

10x Genomics started selling Atera, a new tool that helps scientists study cells. This shows the company has a real product customers want to buy.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.